Results 131 to 140 of about 4,891 (195)

Systematic reassessment of reported variants in individuals with suspicion of Alport spectrum disorder reveals a high rate of ambiguous results. [PDF]

Eur J Hum Genet
Riedhammer KM, Richthammer P, Westphal DS, Ćomić J, Günthner R, Braunisch MC, Büscher AK, Klein HG, Weber S, Hoefele J.   +9 more
europepmc   +1 more source

Multiscale molecular modeling-directed ROS-responsive nanotherapy for dual-axis regulation of fibrotic and inflammatory signaling in alport nephropathy. [PDF]

J Nanobiotechnology
Choi HS, Sundaram A, Vasukutty A, Mathew AP, Sathiyamoorthy P, Kim IJ, Suh SH, Kim CS, Ma SK, Kim SW, Park IK, Bae EH.   +11 more
europepmc   +1 more source

Changes in bone characteristics precede serum mineral deterioration in a mouse model of early stage chronic kidney disease. [PDF]

JBMR Plus
Verlinden L, Stockmans I, Moermans K, Carmeliet G.   +3 more
europepmc   +1 more source

Alport: Renaming an Extended Clinical Spectrum. [PDF]

J Am Soc Nephrol
Lennon R, Miner JH, Savige J, Weinstock BA, Gear S.   +4 more
europepmc   +1 more source

Sequential sequencing reveals the architecture and complexity of genomic variants in patients with Alport syndrome. [PDF]

Nat Commun
Di H, You Z, Wang L, Sun Q, Zhang J, Lv Q, Wang P, Lai Z, Wang G, Zheng C, Gong L, Liu Z.   +11 more
europepmc   +1 more source

Phenotype of autosomal dominant Alport syndrome with a likely pathogenic heterozygous variant in the COL4A3 gene (Gly366Arg) and incidental teratozoospermia: A case report. [PDF]

An Sist Sanit Navar
Martín Moreno V, Martín Fernández A, García Mateos A, Hurtado Gallar J, Angulo García C, Sánchez-Redondo Mayordomo R.   +5 more
europepmc   +1 more source

Unanswered Questions About Microscopic Hematuria With Tubulopathy. [PDF]

Kidney Int Rep
Neild GH, Oygar DD, Behlul A, Ataçi S, Yükseliş M, Özadalı S, Ozdemir F, Kazan HH, Gale DP, Gurkan C.   +9 more
europepmc   +1 more source

Systematic Review of IgA Nephropathy Coexisting With Alport Syndrome. [PDF]

Kidney Int Rep
Ying D, Zhang Y, Ma Y, Wei C, Fan J, Shi P, Wang M, Zhang J.   +7 more
europepmc   +1 more source

Modulation of the Apolipoprotein M/S1PR4 Pathway Reduces Podocyte Lipid Overload in Alport Syndrome via Distinct Autophagy and Efflux Mechanisms. [PDF]

J Am Soc Nephrol
Tolerico M, Molina J, Insenga A, Carrazco A, Njeim R, Sloan A, Griswold A, Kurano M, Mendez A, Nathans R, Bolek R, Ettou S, Berasi S, Fornoni A, Merscher S.   +14 more
europepmc   +1 more source

Sodium-Glucose Cotransporter-2-inhibitors in Adult Patients With Alport Syndrome. [PDF]

Kidney Int Rep
Toso D, Cinquina V, Econimo L, Cortinovis R, Zeni L, Tornambè V, Dordoni C, Ritelli M, Savoldi G, Mazza C, Scolari F, Alberici F, Izzi C.   +12 more
europepmc   +1 more source